[1] Zhu J, Liao L, Bian X, et al. pH-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres[J]. Small, 2012, 8(17):2715-2720.
[2] Sapino S, Ugazio E, Gastaldi L, et al. Mesoporous silica as topical nanocarriers for quercetin:characterization and in vitro studies[J]. Eur J Pharm Biopharm, 2015, 89:116-125.
[3] Zhu W, Zhao Q, Sun C, et al. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity:improve dissolution rate and bioavailability[J]. Mater Sci Eng C Mater Biol Appl, 2014, 39:13-20.
[4] Zhao P, Wang L, Sun C, et al. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study[J]. Eur J Pharm Biopharm, 2012, 80(3):535-543.
[5] 朱杰,廖蕾,朱丽娜,等. 叶酸功能化介孔碳纳米球负载阿霉素的细胞靶向传递及可控释放[J]. 化学学报, 2013, 71(1):69-74.
[6] Zhang X, Zhang T, Ye Y, et al. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112(a Hsp90 inhibitor) with enhanced antitumor effect[J]. Eur J Pharm Biopharm, 2015, 94:30-41.
[7] Zhang Y, Zhao Q, Zhu W, et al. Synthesis and evaluation of mesoporous carbon/lipid bilayer nanocomposites for improved oral delivery of the poorly water-soluble drug, nimodipine[J]. Pharm Res, 2015, 32(7):2372-2383.
[8] Gu J, Su S, Li Y, et al. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs[J]. Chem Commun(Camb), 2011, 47(7):2101-2103.
[9] Fang Y, Gu D, Zou Y, et al. A low-concentration hydrothermal synthesis of biocompatible ordered mesoporous carbon nanospheres with tunable and uniform size[J]. Angew Chem Int Ed Engl, 2010, 49(43):7987-7991.
[10] Zhi X, Fang H, Bao C, et al. The immunotoxicity of graphene oxides and the effect of PVP-coating[J]. Biomaterials, 2013, 34(21):5254-5261.
[11] 王凯苑,孟颖,阎雪莹. PEG-PLGA包裹的介孔碳纳米给药系统的制备和表征[J]. 黑龙江医药, 2015, 28(2):248-251.
[12] Liang H, Jin C, Tang Y, et al. Cytotoxicity of silica nanoparticles on HaCaT cells[J]. J Appl Toxicol, 2014, 34(4):367-372.